T. Rowe Price Associates’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Buy |
277,320
+45,499
| +20% | +$88.8K | ﹤0.01% | 2264 |
|
|
2025
Q1 | $409K | Buy |
231,821
+6,796
| +3% | +$12K | ﹤0.01% | 2330 |
|
|
2024
Q4 | $599K | Buy |
225,025
+9,758
| +5% | +$26K | ﹤0.01% | 2200 |
|
|
2024
Q3 | $493K | Sell |
215,267
-5,052
| -2% | -$11.6K | ﹤0.01% | 2245 |
|
|
2024
Q2 | $644K | Sell |
220,319
-1,134,313
| -84% | -$3.32M | ﹤0.01% | 2086 |
|
|
2024
Q1 | $4.93M | Buy |
1,354,632
+1,146,794
| +552% | +$4.18M | ﹤0.01% | 1220 |
|
|
2023
Q4 | $314K | Sell |
207,838
-584,073
| -74% | -$882K | ﹤0.01% | 2355 |
|
|
2023
Q3 | $1.06M | Sell |
791,911
-13,908
| -2% | -$18.7K | ﹤0.01% | 1763 |
|
|
2023
Q2 | $1.45M | Sell |
805,819
-48,848
| -6% | -$88K | ﹤0.01% | 1609 |
|
|
2023
Q1 | $1.42M | Sell |
854,667
-20,170
| -2% | -$33.5K | ﹤0.01% | 1611 |
|
|
2022
Q4 | $1.68M | Sell |
874,837
-36,696
| -4% | -$70.4K | ﹤0.01% | 1533 |
|
|
2022
Q3 | $2.04M | Buy |
911,533
+826,426
| +971% | +$1.85M | ﹤0.01% | 1444 |
|
|
2022
Q2 | $276K | Buy |
85,107
+34,653
| +69% | +$112K | ﹤0.01% | 2471 |
|
|
2022
Q1 | $265K | Buy |
50,454
+13,212
| +35% | +$69.4K | ﹤0.01% | 2593 |
|
|
2021
Q4 | $317K | Buy |
37,242
+23,166
| +165% | +$197K | ﹤0.01% | 2575 |
|
|
2021
Q3 | $140K | Buy |
14,076
+2,593
| +23% | +$25.8K | ﹤0.01% | 2777 |
|
|
2021
Q2 | $107K | Buy |
+11,483
| New | +$107K | ﹤0.01% | 2830 |
|